Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Aho

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Health Technology Assessment (Winchester, England)|May 30, 2006
Diagnostic tests and algorithms used in the investigation of haematuria: systematic reviews and economic evaluationM Rodgers, J Nixon, S Hempel, et al.
Circulation|October 1, 1994
Cytomegalovirus infection-enhanced allograft arteriosclerosis is prevented by DHPG prophylaxis in the ratK B Lemström, J H Bruning, C A Bruggeman, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 6, 2007
Practical issues in the implementation of image-guided radiotherapy for the treatment of prostate cancer within a UK departmentY L Rimmer, N G Burnet, D S Routsis, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Health Technology Assessment (Winchester, England)|May 30, 2006
Diagnostic tests and algorithms used in the investigation of haematuria: systematic reviews and economic evaluationM Rodgers, J Nixon, S Hempel, et al.
Circulation|October 1, 1994
Cytomegalovirus infection-enhanced allograft arteriosclerosis is prevented by DHPG prophylaxis in the ratK B Lemström, J H Bruning, C A Bruggeman, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 6, 2007
Practical issues in the implementation of image-guided radiotherapy for the treatment of prostate cancer within a UK departmentY L Rimmer, N G Burnet, D S Routsis, et al.
Pageof 2